Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delstrigo for non-occupational HIV post-exposure prophylaxis (Spain)
2019-004140-30Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of doravirine in human immunodeficiency virus infection (HIV), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Treatment completion at day 28. Started Jan 2020; status: completed.
02
Drugs
doravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2019-004140-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004140-30.